New Immunotherapy for Liver Cancer

Cancer Health Treatment Update FDA Approves New Immunotherapy for Advanced Liver Cancer Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma. The Message Hasn’t Changed: Get Colorectal Cancer Screening Despite confusing media coverage of a study relating to colonoscopies, they are an effective tool in reducing colorectal cancer risk. Immunotherapy Before Surgery Appears Effective for Some with Melanoma The approach appears to benefit people with advanced forms of the disease but whose cancer can still be treated with surgery. FDA OKs Drug to Reduce Hearing Loss in Kids With Cancer Pedmark (sodium thiosulfate) is the first med approved to lower risk of hearing loss in children treated with cisplatin chemotherapy. News from the ESMO Congress See all reports from Europe's largest cancer conference. Advertisement Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page. Cancer Patients on Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines Plus, the vaccines offer strong protection from severe COVID-19 for all variants for people treated with immunotherapy. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Fall 2022 Check out our latest print edition! Newsfeed Mary J. Blige’s Personal Losses Led Her to Support Biden’s Cancer Moonshot Jill Biden Discusses Breast Cancer Research at UCSF 22 NFL Players Raise Cancer Screening Awareness Through “Crucial Catch” Continued Access to Fertility Preservation Critical for Adolescent and Young Adult Cancer Patients Blog: National Cancer Institute Immunotherapy Before Surgery Appears Effective for Some with Melanoma FDA OKs Drug to Reduce Hearing Loss in Kids With Cancer Researchers Identify Potential Treatment for Gliomas Enhertu Marks First Targeted Therapy for HER2-Mutant Lung Cancer Newsfeed Mary J. Blige’s Personal Losses Led Her to Support Biden’s Cancer Moonshot Jill Biden Discusses Breast Cancer Research at UCSF 22 NFL Players Raise Cancer Screening Awareness Through “Crucial Catch” Continued Access to Fertility Preservation Critical for Adolescent and Young Adult Cancer Patients Blog: National Cancer Institute Immunotherapy Before Surgery Appears Effective for Some with Melanoma FDA OKs Drug to Reduce Hearing Loss in Kids With Cancer Researchers Identify Potential Treatment for Gliomas Enhertu Marks First Targeted Therapy for HER2-Mutant Lung Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.
To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.
To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.
Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.
Our mailing address is:

Smart + Strong157 Columbus Avenue, Suite 525New York, NY 10023
Add us to your address book Copyright (C) 2022 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.